Giordano International Stock
Your prediction
Giordano International Stock
Giordano International shows a slight decrease today, losing -€0.001 (-0.720%) compared to yesterday.
Pros and Cons of Giordano International in the next few years
Pros
?
B****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Giordano International vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Giordano International | -0.720% | -0.719% | -2.817% | -14.286% | -4.828% | -61.878% | -14.815% |
| Bosideng International Holdings Ltd | -0.980% | -1.905% | -2.830% | - | 5.102% | - | - |
| Glorious Sun Enterprises Ltd | 0.740% | 0.741% | 0.000% | -1.449% | -2.857% | 63.855% | 80.132% |
| Emperor Watch&jewellery | -4.170% | 0.000% | 4.545% | -36.986% | 35.294% | 35.294% | 24.324% |
News
Tenax LEVEL Trial Misses Primary Goal, but Subgroup Data Bolsters Levosimendan Case
Key Points
- Interested in Tenax Therapeutics, Inc.? Here are five stocks we like better.
- Tenax’s Phase III LEVEL trial missed its primary endpoint: Oral levosimendan improved six-minute walk
Here's Why Vertiv Shares Popped Higher in April
Vertiv (NYSE: VRT) stock is up an incredible 121.5% in 2026 as I write, and it rose by 31.1% in April alone, according to data from S&P Global Market Intelligence. The move in April came in a month
